BioSpace News Archive

Orthofix Medical Inc. today reported its financial results for the quarter ended September 30, 2021.

Applied UV, Inc. announced today that its SteriLumen Lumicide™ Ribbon kills the emerging multi-drug resistant fungus, Candida auris (“C. auris”).

bluebird bio, Inc. (NASDAQ: BLUE) today reported financial results and business highlights for the third quarter ended September 30, 2021.

InflaRx announced today financial and operating results for the three and nine months ended September 30, 2021.

Tris Pharma, Inc. (Tris) announced today that the U.S. Food and Drug Administration has approved Dyanavel XR (amphetamine) for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.

Bio-Path Holdings, Inc. announced that it will host a live conference call and audio webcast on Friday, November 12, 2021 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2021 and to provide a business overview.

Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy to treat severely calcified cardiovascular disease, unveiled new data confirming the safety and effectiveness of coronary IVL out to one year, a new gender analysis that found similar outcomes between men and women, and an OCT analysis that found consistent acute performance in eccentric, concentric and nodular calcified lesions.

Syros Pharmaceuticals today reported financial results for the quarter ended September 30, 2021, and provided an update on recent accomplishments and upcoming events.

Surrozen, Inc. today announced that Craig Parker, Chief Executive Officer, will present at the Stifel 2021 Virtual Healthcare Conference at 4:40 p.m. ET on Tuesday, November 16.

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to 15 new employees.